Click for best price
Genital Herpes Treatment Drugs Market Size, Share 2022
Genital herpes is a sexually transmitted disease (STD). This STD causes herpetic sores, which are painful blisters (fluid-filled bumps) that can break open and ooze fluid. About 16 percentTrusted Source of people between the ages of 14 and 49 have this STD.
This report contains market size and forecasts of Genital Herpes Treatment Drugs in Global, including the following market information:
Global Genital Herpes Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Genital Herpes Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Acyclovir Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Genital Herpes Treatment Drugs include AstraZeneca, Plc., Apotheca, Inc., Asahi Kasei Pharma Corporation, Carlsbad Technology, Inc., GlaxoSmithkline, Plc., Mylan N.V., Novartis AG., Merck & Co., Inc. and Teva Pharmaceutical Industries Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Genital Herpes Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genital Herpes Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Genital Herpes Treatment Drugs Market Segment Percentages, by Type, 2021 (%)
Acyclovir
Famciclovir
Valacyclovir
Global Genital Herpes Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Genital Herpes Treatment Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Genital Herpes Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Genital Herpes Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Genital Herpes Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Genital Herpes Treatment Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca, Plc.
Apotheca, Inc.
Asahi Kasei Pharma Corporation
Carlsbad Technology, Inc.
GlaxoSmithkline, Plc.
Mylan N.V.
Novartis AG.
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Zydus Pharmaceuticals, Inc.
| Report Attributes |
Report Details |
| Report Title |
Genital Herpes Treatment Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Genital Herpes Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genital Herpes Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genital Herpes Treatment Drugs Overall Market Size
2.1 Global Genital Herpes Treatment Drugs Market Size: 2021 VS 2028
2.2 Global Genital Herpes Treatment Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Genital Herpes Treatment Drugs Players in Global Market
3.2 Top Global Genital Herpes Treatment Drugs Companies Ranked by Revenue
3.3 Global Genital Herpes Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Genital Herpes Treatment Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Genital Herpes Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genital Herpes Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Genital Herpes Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Genital Herpes Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Genital Herpes Treatment Drugs Market Size Markets, 2021 & 2028
4.1.2 Acyclovir
4.1.3 Famciclovir
4.1.4 Valacyclovir
4.2 By Type - Global Genital Herpes Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Genital Herpes Treatment Drugs Revenue, 2017-2022
4.2.2 By Type - Global Genital Herpes Treatment Drugs Revenue, 2023-2028
4.2.3 By Type - Global Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Genital Herpes Treatment Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Genital Herpes Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Genital Herpes Treatment Drugs Revenue, 2017-2022
5.2.2 By Application - Global Genital Herpes Treatment Drugs Revenue, 2023-2028
5.2.3 By Application - Global Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Genital Herpes Treatment Drugs Market Size, 2021 & 2028
6.2 By Region - Global Genital Herpes Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Genital Herpes Treatment Drugs Revenue, 2017-2022
6.2.2 By Region - Global Genital Herpes Treatment Drugs Revenue, 2023-2028
6.2.3 By Region - Global Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Genital Herpes Treatment Drugs Revenue, 2017-2028
6.3.2 US Genital Herpes Treatment Drugs Market Size, 2017-2028
6.3.3 Canada Genital Herpes Treatment Drugs Market Size, 2017-2028
6.3.4 Mexico Genital Herpes Treatment Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Genital Herpes Treatment Drugs Revenue, 2017-2028
6.4.2 Germany Genital Herpes Treatment Drugs Market Size, 2017-2028
6.4.3 France Genital Herpes Treatment Drugs Market Size, 2017-2028
6.4.4 U.K. Genital Herpes Treatment Drugs Market Size, 2017-2028
6.4.5 Italy Genital Herpes Treatment Drugs Market Size, 2017-2028
6.4.6 Russia Genital Herpes Treatment Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Genital Herpes Treatment Drugs Market Size, 2017-2028
6.4.8 Benelux Genital Herpes Treatment Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Genital Herpes Treatment Drugs Revenue, 2017-2028
6.5.2 China Genital Herpes Treatment Drugs Market Size, 2017-2028
6.5.3 Japan Genital Herpes Treatment Drugs Market Size, 2017-2028
6.5.4 South Korea Genital Herpes Treatment Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Genital Herpes Treatment Drugs Market Size, 2017-2028
6.5.6 India Genital Herpes Treatment Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Genital Herpes Treatment Drugs Revenue, 2017-2028
6.6.2 Brazil Genital Herpes Treatment Drugs Market Size, 2017-2028
6.6.3 Argentina Genital Herpes Treatment Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Genital Herpes Treatment Drugs Revenue, 2017-2028
6.7.2 Turkey Genital Herpes Treatment Drugs Market Size, 2017-2028
6.7.3 Israel Genital Herpes Treatment Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Genital Herpes Treatment Drugs Market Size, 2017-2028
6.7.5 UAE Genital Herpes Treatment Drugs Market Size, 2017-2028
7 Players Profiles
7.1 AstraZeneca, Plc.
7.1.1 AstraZeneca, Plc. Corporate Summary
7.1.2 AstraZeneca, Plc. Business Overview
7.1.3 AstraZeneca, Plc. Genital Herpes Treatment Drugs Major Product Offerings
7.1.4 AstraZeneca, Plc. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.1.5 AstraZeneca, Plc. Key News
7.2 Apotheca, Inc.
7.2.1 Apotheca, Inc. Corporate Summary
7.2.2 Apotheca, Inc. Business Overview
7.2.3 Apotheca, Inc. Genital Herpes Treatment Drugs Major Product Offerings
7.2.4 Apotheca, Inc. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.2.5 Apotheca, Inc. Key News
7.3 Asahi Kasei Pharma Corporation
7.3.1 Asahi Kasei Pharma Corporation Corporate Summary
7.3.2 Asahi Kasei Pharma Corporation Business Overview
7.3.3 Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Major Product Offerings
7.3.4 Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.3.5 Asahi Kasei Pharma Corporation Key News
7.4 Carlsbad Technology, Inc.
7.4.1 Carlsbad Technology, Inc. Corporate Summary
7.4.2 Carlsbad Technology, Inc. Business Overview
7.4.3 Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Major Product Offerings
7.4.4 Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.4.5 Carlsbad Technology, Inc. Key News
7.5 GlaxoSmithkline, Plc.
7.5.1 GlaxoSmithkline, Plc. Corporate Summary
7.5.2 GlaxoSmithkline, Plc. Business Overview
7.5.3 GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Major Product Offerings
7.5.4 GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.5.5 GlaxoSmithkline, Plc. Key News
7.6 Mylan N.V.
7.6.1 Mylan N.V. Corporate Summary
7.6.2 Mylan N.V. Business Overview
7.6.3 Mylan N.V. Genital Herpes Treatment Drugs Major Product Offerings
7.6.4 Mylan N.V. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.6.5 Mylan N.V. Key News
7.7 Novartis AG.
7.7.1 Novartis AG. Corporate Summary
7.7.2 Novartis AG. Business Overview
7.7.3 Novartis AG. Genital Herpes Treatment Drugs Major Product Offerings
7.7.4 Novartis AG. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.7.5 Novartis AG. Key News
7.8 Merck & Co., Inc.
7.8.1 Merck & Co., Inc. Corporate Summary
7.8.2 Merck & Co., Inc. Business Overview
7.8.3 Merck & Co., Inc. Genital Herpes Treatment Drugs Major Product Offerings
7.8.4 Merck & Co., Inc. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.8.5 Merck & Co., Inc. Key News
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.9.3 Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.9.5 Teva Pharmaceutical Industries Ltd. Key News
7.10 Zydus Pharmaceuticals, Inc.
7.10.1 Zydus Pharmaceuticals, Inc. Corporate Summary
7.10.2 Zydus Pharmaceuticals, Inc. Business Overview
7.10.3 Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Major Product Offerings
7.10.4 Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.10.5 Zydus Pharmaceuticals, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Genital Herpes Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Genital Herpes Treatment Drugs Market Drivers in Global Market
Table 3. Genital Herpes Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Genital Herpes Treatment Drugs in Global Market
Table 5. Top Genital Herpes Treatment Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Genital Herpes Treatment Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Genital Herpes Treatment Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Genital Herpes Treatment Drugs Product Type
Table 9. List of Global Tier 1 Genital Herpes Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genital Herpes Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Genital Herpes Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Genital Herpes Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Genital Herpes Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Genital Herpes Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Genital Herpes Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Genital Herpes Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca, Plc. Corporate Summary
Table 31. AstraZeneca, Plc. Genital Herpes Treatment Drugs Product Offerings
Table 32. AstraZeneca, Plc. Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Apotheca, Inc. Corporate Summary
Table 34. Apotheca, Inc. Genital Herpes Treatment Drugs Product Offerings
Table 35. Apotheca, Inc. Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Asahi Kasei Pharma Corporation Corporate Summary
Table 37. Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Product Offerings
Table 38. Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Carlsbad Technology, Inc. Corporate Summary
Table 40. Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Product Offerings
Table 41. Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithkline, Plc. Corporate Summary
Table 43. GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Product Offerings
Table 44. GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Mylan N.V. Corporate Summary
Table 46. Mylan N.V. Genital Herpes Treatment Drugs Product Offerings
Table 47. Mylan N.V. Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Novartis AG. Corporate Summary
Table 49. Novartis AG. Genital Herpes Treatment Drugs Product Offerings
Table 50. Novartis AG. Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Merck & Co., Inc. Corporate Summary
Table 52. Merck & Co., Inc. Genital Herpes Treatment Drugs Product Offerings
Table 53. Merck & Co., Inc. Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 55. Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Product Offerings
Table 56. Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Zydus Pharmaceuticals, Inc. Corporate Summary
Table 58. Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Product Offerings
Table 59. Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Genital Herpes Treatment Drugs Segment by Type in 2021
Figure 2. Genital Herpes Treatment Drugs Segment by Application in 2021
Figure 3. Global Genital Herpes Treatment Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Genital Herpes Treatment Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Genital Herpes Treatment Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genital Herpes Treatment Drugs Revenue in 2021
Figure 8. By Type - Global Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
Figure 12. US Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
Figure 24. China Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca, Plc. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Apotheca, Inc. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Mylan N.V. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis AG. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck & Co., Inc. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
